Rubicon Founders completed the $165m investment in Caidya.

Rubicon Founders, a healthcare investment firm, completed the $165m investment in Caidya, a global mid-sized CRO. “We are extremely excited to get Rubicon Founders’ support as Caidya embarks on our next phase of growth and transformation. Rubicon Founders will bring tremendous expertise and resources to accelerate our global growth, in full alignment with our aspiration to be the leading mid-sized CRO serving biopharma innovation across the Americas, Europe, and Asia-Pacific,” Barbara Lopez Kunz, Caidya CEO.